These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25407394)

  • 1. Rational stabilization of helix 2 of the prion protein prevents its misfolding and oligomerization.
    Singh J; Kumar H; Sabareesan AT; Udgaonkar JB
    J Am Chem Soc; 2014 Dec; 136(48):16704-7. PubMed ID: 25407394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural effects of multiple pathogenic mutations suggest a model for the initiation of misfolding of the prion protein.
    Singh J; Udgaonkar JB
    Angew Chem Int Ed Engl; 2015 Jun; 54(26):7529-33. PubMed ID: 25959220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Molecular Mechanism of pH-Induced Misfolding and Oligomerization of the Prion Protein.
    Singh J; Udgaonkar JB
    J Mol Biol; 2016 Mar; 428(6):1345-1355. PubMed ID: 26854758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pathogenic Mutation T182A Converts the Prion Protein into a Molten Globule-like Conformation Whose Misfolding to Oligomers but Not to Fibrils Is Drastically Accelerated.
    Singh J; Udgaonkar JB
    Biochemistry; 2016 Jan; 55(3):459-69. PubMed ID: 26713717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatics in the stability and misfolding of the prion protein: salt bridges, self energy, and solvation.
    Guest WC; Cashman NR; Plotkin SS
    Biochem Cell Biol; 2010 Apr; 88(2):371-81. PubMed ID: 20453937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracysteine-tagged prion protein allows discrimination between the native and converted forms.
    Gaspersic J; Hafner-Bratkovic I; Stephan M; Veranic P; Bencina M; Vorberg I; Jerala R
    FEBS J; 2010 May; 277(9):2038-50. PubMed ID: 20345906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mutations within the Disordered Palindromic Region of the Prion Protein Induce Structure Therein and Accelerate the Formation of Misfolded Oligomers.
    Sabareesan AT; Udgaonkar JB
    J Mol Biol; 2016 Oct; 428(20):3935-3947. PubMed ID: 27545411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of infectious prions: stabilization by domain swapping.
    Yang S; Levine H; Onuchic JN; Cox DL
    FASEB J; 2005 Nov; 19(13):1778-82. PubMed ID: 16260647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
    Colacino S; Tiana G; Broglia RA; Colombo G
    Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem-forming regions that are essential for the amyloidogenesis of prion proteins.
    Saiki M; Hidaka Y; Nara M; Morii H
    Biochemistry; 2012 Feb; 51(8):1566-76. PubMed ID: 22324778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar folds with different stabilization mechanisms: the cases of Prion and Doppel proteins.
    Colacino S; Tiana G; Colombo G
    BMC Struct Biol; 2006 Jul; 6():17. PubMed ID: 16857062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced stability of human prion proteins with two disulfide bridges.
    Knowles TP; Zahn R
    Biophys J; 2006 Aug; 91(4):1494-500. PubMed ID: 16751235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct morphological and electrophysiological properties of an elk prion peptide.
    Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
    Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein misfolding and prion diseases.
    Cohen FE
    J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison studies of the structural stability of rabbit prion protein with human and mouse prion proteins.
    Zhang J
    J Theor Biol; 2011 Jan; 269(1):88-95. PubMed ID: 20970434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of prion inhibition by phenothiazine compounds.
    Baral PK; Swayampakula M; Rout MK; Kav NN; Spyracopoulos L; Aguzzi A; James MN
    Structure; 2014 Feb; 22(2):291-303. PubMed ID: 24373770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating the conformation of prion protein through ligand binding.
    Yamamoto N; Kuwata K
    J Phys Chem B; 2009 Oct; 113(39):12853-6. PubMed ID: 19725511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions: a model of conformational disease?
    Morinet F
    Pathol Biol (Paris); 2014 Apr; 62(2):96-9. PubMed ID: 24656441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.